C7H 6 N 6 O4, monoclinic, P21/c (no. 14), a = 21.0402 (7) Å, b = 7.9959(3) Å, c = 11.8012(4) Å, β = 102.379(1)°, V = 1939.22(12) Å 3 , Z = 8, Rgt(F) = 0.0481, wR ref (F 2 ) = 0.1296, T = 170 K.
Experimental details
All H atoms were positioned geometrically and treated as riding, with N-H bond 0.88 Å and U iso (H) = 1.2Ueq(N). Difference electron density peaks and holes near N1 suggest a small (not introduced) disorder at that group.
Discussion
Nitroimidazole derivatives is one of the research focuses on energetic materials [5, 6] . A series of compounds have been synthesized, such as 1,4-dinitroimidazole, 2,4dinitroimidazole, 2,4,5-trinitroimidazole and 1-methyl-2,4, 5-trinitroimidazole, etc. [7] [8] [9] [10] . Nitroimidazole derivatives bridged by methylene are also expected to become a new energetic material, the title compound is one of them. Here we report the crystal structure of the title compound (cf. the figure) .
The asymmetric unit of the title structure contains two crystallographically independent bis(4-Nitroimidazol-1yl-)methane molecules. The imidazole ring and nitro is almost flat.
